FDA-Approved Radiopharmaceutical Supplies and Cold Kits

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEFENSE HEALTH AGENCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

HT9406-26-Q-E102

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

NONE

Place of Performance

Fort Gordon, Georgia, UNITED STATES

SourceSAM
Documents4
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a Combined Synopsis/Solicitation for the procurement of FDA-approved radiopharmaceutical supplies and cold kits. This requirement is intended to support the Nuclear Medicine Section at the Dwight David Eisenhower Army Medical Center (DDEAMC), located at Fort Gordon, Georgia. The procurement identifier for this opportunity is HT9406-26-Q-E102. The scope of this contract encompasses the continuous provision, custom compounding, and timely delivery of radiopharmaceuticals and cold kits that are FDA-approved. The contractor will be responsible for supplying all necessary personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items and non-personal services required to fulfill the needs of the medical center’s nuclear medicine operations. The objective is to ensure uninterrupted access to these critical medical supplies, supporting diagnostic and therapeutic procedures within the facility. Key requirements include the ability to provide custom compounding services and maintain a reliable delivery schedule to meet the operational demands of DDEAMC. All products must comply with FDA approval standards, and the contractor must demonstrate the capacity to manage logistics and quality control for pharmaceutical preparation manufacturing, as classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version). The relevant Product Service Code is 6505, which pertains to drugs and biologicals. There are no set-aside requirements for this procurement; it is open to all qualified vendors. The place of performance is Fort Gordon, Georgia, United States. Contractors should note that the contract will be administered by the Defense Health Agency, with primary and secondary points of contact provided: Sherina Ross ([email protected]) and Lenore Y. Paseda ([email protected]). The notice is currently active, with a posting date of March 9, 2026, and a response deadline of October 9, 2026. Interested parties can access further details and attachments via the SAM.gov opportunity link: https://sam.gov/opp/0fc5157263df4e63a9763e6e8c182131/view. This procurement represents a critical support function for military healthcare operations, requiring contractors with proven expertise in pharmaceutical preparation, compounding, and logistics. The contract’s requirements and objectives are expected to remain consistent throughout its lifecycle, focusing on quality, reliability, and compliance with regulatory standards.